These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2872111)

  • 41. Lethal infection by Bordetella pertussis mutants in the infant mouse model.
    Weiss AA; Goodwin MS
    Infect Immun; 1989 Dec; 57(12):3757-64. PubMed ID: 2572561
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells.
    Tuomanen E; Weiss A
    J Infect Dis; 1985 Jul; 152(1):118-25. PubMed ID: 2861240
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools.
    Carbonetti NH
    Future Microbiol; 2010 Mar; 5(3):455-69. PubMed ID: 20210554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Filamentous hemagglutinin has a major role in mediating adherence of Bordetella pertussis to human WiDr cells.
    Urisu A; Cowell JL; Manclark CR
    Infect Immun; 1986 Jun; 52(3):695-701. PubMed ID: 2872165
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Evaluation of Bordetella pertussis strains toxicity in vitro using CHO cell lines].
    Zawadka M; Rabczenko D; Lutyńska A
    Med Dosw Mikrobiol; 2014; 66(3-4):185-94. PubMed ID: 25804072
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Separation and purification of the hemagglutinins from Bordetella pertussis.
    Sato Y; Cowell JL; Sato H; Burstyn DG; Manclark CR
    Infect Immun; 1983 Jul; 41(1):313-20. PubMed ID: 6305841
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new assay for invasion of HeLa 229 cells by Bordetella pertussis: effects of inhibitors, phenotypic modulation, and genetic alterations.
    Lee CK; Roberts AL; Finn TM; Knapp S; Mekalanos JJ
    Infect Immun; 1990 Aug; 58(8):2516-22. PubMed ID: 2370104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dermonecrotic toxin and tracheal cytotoxin, putative virulence factors of Bordetella avium.
    Gentry-Weeks CR; Cookson BT; Goldman WE; Rimler RB; Porter SB; Curtiss R
    Infect Immun; 1988 Jul; 56(7):1698-707. PubMed ID: 3384473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro.
    Hoffman C; Eby J; Gray M; Heath Damron F; Melvin J; Cotter P; Hewlett E
    Mol Microbiol; 2017 Jan; 103(2):214-228. PubMed ID: 27731909
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differentiation of phase I and variant strains of Bordetella pertussis on Congo red media.
    Parton R
    J Med Microbiol; 1988 Aug; 26(4):301-6. PubMed ID: 2899648
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospects for a new acellular pertussis vaccine.
    Manclark CR; Burns DL
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):323-9. PubMed ID: 2870676
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bordetella pertussis infection of human monocytes inhibits antigen-dependent CD4 T cell proliferation.
    Boschwitz JS; Batanghari JW; Kedem H; Relman DA
    J Infect Dis; 1997 Sep; 176(3):678-86. PubMed ID: 9291315
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pertussis toxin and lipopolysaccharide influence phagocytosis of Bordetella pertussis by human monocytes.
    Schaeffer LM; Weiss AA
    Infect Immun; 2001 Dec; 69(12):7635-41. PubMed ID: 11705943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of functional complementation between Bordetella pertussis filamentous hemagglutinin and Proteus mirabilis HpmA hemolysin secretion machineries.
    Jacob-Dubuisson F; Buisine C; Willery E; Renauld-Mongénie G; Locht C
    J Bacteriol; 1997 Feb; 179(3):775-83. PubMed ID: 9006033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phase variation in Bordetella pertussis is accompanied by changes in DNA modification.
    Goldman S; Navon Y; Fish F
    Microb Pathog; 1987 May; 2(5):327-38. PubMed ID: 2907087
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulation of Bordetella pertussis adenylate cyclase toxin intoxication by its hemolysin domain.
    Iwaki M; Kamachi K; Konda T
    Infect Immun; 2000 Jun; 68(6):3727-30. PubMed ID: 10816536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Use of cyclodextrin as an agent to induce excretion of Bordetella pertussis antigens.
    Hozbor D; Rodriguez ME; Yantorno O
    FEMS Immunol Med Microbiol; 1994 Aug; 9(2):117-24. PubMed ID: 7804162
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The phenotypic properties of freshly isolated strains of Bordetella].
    Lapaeva IA; Milanko AIa; Mebel' SM; Siniashina LN; Ferkel' GIa; Khramova NN; Tepliakova AI; Lomonosova GG; Volgina TI; Shumakov IuL
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Mar; (3):13-6. PubMed ID: 1678567
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutagenesis of Bordetella pertussis with transposon Tn5tac1: conditional expression of virulence-associated genes.
    Cookson BT; Berg DE; Goldman WE
    J Bacteriol; 1990 Apr; 172(4):1681-7. PubMed ID: 2156797
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo and in vitro analysis of Bordetella pertussis catalase and Fe-superoxide dismutase mutants.
    Khelef N; DeShazer D; Friedman RL; Guiso N
    FEMS Microbiol Lett; 1996 Sep; 142(2-3):231-5. PubMed ID: 8810507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.